The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2022

Filed:

Nov. 06, 2017
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Natalia A. Trayanova, Baltimore, MD (US);

Adityo Prakosa, Baltimore, MD (US);

Mark Cartoski, Parkville, MD (US);

Patrick M. Boyle, Baltimore, MD (US);

Assignee:

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); G16H 50/50 (2018.01); G16H 50/30 (2018.01); G16H 30/40 (2018.01); A61B 5/055 (2006.01); G01R 33/56 (2006.01);
U.S. Cl.
CPC ...
A61B 5/7275 (2013.01); A61B 5/0044 (2013.01); A61B 5/055 (2013.01); A61B 5/7207 (2013.01); A61B 5/7264 (2013.01); G01R 33/5601 (2013.01); G01R 33/5608 (2013.01); G16H 30/40 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); A61B 2576/023 (2013.01);
Abstract

An embodiment in accordance with the present invention provides a non-invasive solution to risk stratify the risk of in arrhythmia in patients with TOF. Currently, no reliable method for non-invasive risk stratification exists. In the realm of congenital heart disease, cardiac MRI is now used routinely for patients with Tetralogy of Fallot (TOF), the most common form of cyanotic congenital heart disease. An innovative platform for using clinical MRI data to create 3D electromechanical models of the heart enables predictions of whether or not patients with ischemic heart disease have the substrate for arrhythmia and what their relative risk for such an event is. An embodiment of the current invention provides a non-invasive solution to risk stratify the risk of arrhythmia in patients with TOF. Currently, no reliable method for non-invasive risk stratification exists.


Find Patent Forward Citations

Loading…